We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
-3.18%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$396M
AUM Growth
+$11.3M
(+2.9%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
5.7%
Top 10 Holdings %
Top 10 Hldgs %
81.75%
Holding
27
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$73.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$30.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.64% |
| 2 | Financials | 7.29% |
| 3 | Technology | 4.17% |
| 4 | Healthcare | 2.55% |
| 5 | Communication Services | 2.47% |
Similar funds
VM
SSC
ACM
MCM
MIA
SP
TI
SWC
Howard Hughes Medical Institute's Q2 2018 Portfolio in Review
As of Q2 2018, Howard Hughes Medical Institute held 27 positions worth $396M, up 2.9% from $384M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Howard Hughes Medical Institute deployed $22.5M of net new capital in Q2 2018, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.6% of assets, down from 9.7% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $30.6M trimmed.
- Howard Hughes Medical Institute added most to iShares MSCI Emerging Markets ETF in Q2 2018, an estimated $73.4M increase.
- Howard Hughes Medical Institute's biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $30.6M.
- Howard Hughes Medical Institute's ten largest holdings make up 82% of its $396M portfolio in Q2 2018.
- Howard Hughes Medical Institute opened 0 new positions and closed 0 in Q2 2018.
- Howard Hughes Medical Institute's portfolio value rose 2.9% quarter-over-quarter to $396M.
Based on Howard Hughes Medical Institute's 13F filing for Q2 2018, filed 31 Jul 2018.